Galderma announces new data demonstrating the positive anti-inflammatory effect and mode of action of nemolizumab in patients with moderate to severe Prurigo Nodularis Press release
RESTYLANE®, the original stabilized hyaluronic acid filler, celebrates 25 years of unmatched achievement Press release
Galderma presents new nemolizumab data at EADV reinforcing rapid onset of action and consistent relief of symptoms for people with prurigo nodularis and atopic dermatitis Press release
Galderma to unveil ground-breaking data from across its leading dermatology portfolio and showcase major update for sensitive skincare brand CETAPHIL® at the 2021 EADV Congress Press release
Galderma and CETAPHIL® Announce Renewed Commitment to Environmental Sustainability and Social Impact Through New Clear Skies Initiative Press release
Galderma announces exclusive agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology Press release
Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE® EYELIGHT™ at AMWC 2021 Press release
Sol-Gel Technologies and Galderma announce exclusive licenses for the commercialization of EPSOLAY® and TWYNEO® in the United States Press release
Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe Press release
